The development of new antidepressants: focus on duloxetine and escitalopram.
Huffman
Jeff C
JC
Massachusetts General Hospital, 15 Parkman St., Wang 812, Boston, MA 02114, USA. jhuffman@partners.org
Perlis
Roy H
RH
D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015283:Citalopram / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D000068736:Duloxetine Hydrochloride; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*
D000928:Antidepressive Agents; D015283:Citalopram; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes